AGPV
AGPV, a tetrapeptide, has the potential for prevention of schistosome parasite infection research[1].
Product Specifications
CAS Number
154485-78-6
UNSPSC
12352209
Target
Parasite
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/agpv.html
Solubility
10 mM in DMSO
Smiles
CC(C)[C@@H](C(O)=O)NC([C@H]1N(CCC1)C(CNC([C@@H](N)C)=O)=O)=O
Molecular Formula
C15H26N4O5
Molecular Weight
342.39
References & Citations
[1]James H. McKerrow, et al. Synthetic tetrapeptides for the prevention of schistosome parasite infection. US5284829A.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
Schistosome
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15142077 1 Vial
Lentiviral human C6orf201 shRNA (UAS) - Lentiviral human C6orf201 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
032365-FITC 200 µL
B4GALT5, CT (B4GALT5, Beta-1,4-galactosyltransferase 5, Beta-1,4-GalT II, UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5, UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5) (FITC) discontinued
Sign In for Pricing
View Details